Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2024 Earnings Call Transcript May 7, 2024
Harvard Bioscience, Inc. misses on earnings expectations. Reported EPS is $-0.10815 EPS, expectations were $0.02. Harvard Bioscience, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good day, and thank you for standing by. Welcome to the Q1 2024 Harvard Bioscience Inc. Earnings Conference Call. [Operator Instructions] Please be...
